• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Belgium·Healthcare·MLBON.PA
Share

bonyf N.V. Stocks

€ 4.2Last Updated 08.06.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

€ 2.85M

€ 4.2
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

bonyf N.V. is a Belgian firm dedicated to the research, development, manufacturing, and distribution of a diverse range of oral and dental healthcare products. Its specialized offerings include PerioTabs, a brushing solution crafted for gums, teeth, and dental implants to mitigate conditions such as gingivitis, periodontitis, peri-mucositis, and peri-implantitis. Another key product is AphtoFix, a film-forming cream designed for the localized treatment of mouth ulcers. The company provides an extensive line of denture care items, featuring OlivaFix and Superior denture adhesive creams, alongside NitrAdine disinfecting denture tabs for hygiene. For repairs, bonyf offers Denture Repair-fix, an immediate solution for fractured dentures or detached teeth, and Fixobridge, a ready-to-use cement for reattaching dislodged crowns, inlays, and bridges. Complementing these are denture relining cushions for improving the fit of ill-fitting dentures, effervescent denture cleanser tabs, and Cavifix, a synthetic resin-based material for temporarily sealing new cavities and repairing lost fillings. Beyond general dental care, bonyf N.V. extends into orthodontic solutions with NitrAdine Ortho & Junior disinfecting tabs, formulated to clean and sanitize removable orthodontic appliances. Furthermore, its portfolio includes wound care products like HeelFix and FingerFix paste dressings, specifically designed to address cracked and chapped skin on the feet and hands. Established in 1979, the company's corporate headquarters are located in Gent, Belgium.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is underpriced on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

13.06.2026 01:04

SpaceX shares slowed before closing in first trading since record IPO

13.06.2026 00:44

Retail investors bought $15 billion worth of SpaceX stock. Demand was at least 6 times that amount

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026